Drugs of the Future
A leading international, peer-reviewed biomedical research journal publishing articles on topics emerging from the confluence of fields including chemistry, biology, pharmacology, genomics and medicine, and addressed to scientists and researchers involved in drug design, discovery and development, target identification and validation, and the preclinical and clinical development of treatments for common as well as rare and neglected diseases and conditions.
The journal publishes monographs containing comprehensive product information on new compounds in development, including synthesis, preclinical pharmacology, pharmacokinetics and metabolism, safety, clinical studies and drug interactions, as well as review articles on a variety of topics, congress and meeting reports.
- Does not allow reviews to be publicly displayed
- Only allows reviewers to display the journal they reviewed for
- Does not allow reviewers to sign or publicly display reviews of rejected publications subsequently published in another journal
Interested in reviewing for this journal?
Your interest in reviewing is shared with journals or conferences when they are partnered with us. Learn more.
Editorial board members on Publons
No one has yet noted that they are on Drugs of the Future's editorial board. If you're on the editorial board of Drugs of the Future, you can add it in your profile settings.
Top reviewers on Publons (Manuscripts reviewed in last 12 months)
Review contents for Drugs of the Future are not publicly displayed on Publons, in accordance with their editorial policy.